Cd133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas

Pancreas

Volumn 38, Issue 8, 2009, Pages

  Shimizu, Kazuya ^a   Itoh, Tomoo ^b   Shimizu, Michio ^c   Ku, Yonson ^b   Hori, Yuichi ^b  

^a Graduate School of Health Sciences   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cancer stem cell; CD133; Intraductal papillary mucinous neoplasm; IPMN; Pancreas; Stem cell

Indexed keywords

CD133 ANTIGEN; MUCIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MUCINOUS CARCINOMA; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SOLID TUMOR;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; ANTIGENS, CD; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PEPTIDES; SENSITIVITY AND SPECIFICITY;

EID: 70350680818     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bb5037     Document Type: Article

References (30)

1. Hruban RH, Wilentz RE, Maitra A. Identification and analysis of precursors to invasive pancreatic cancer. Methods Mol Med. 2005;103:1-13.
2. Maitra A, Fukushima N, Takaori K, et al. Precursors to invasive pancreatic cancer. Adv Anat Pathol. 2005;12:81-91.
3. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-987.
4. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; 6:17-32.
5. Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999; 134:1131-1136.
6. Aguirre AJ, Bardeesy N, Sinha M, et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 2003;17:3112-3126.
7. Miyamoto Y, Maitra A, Ghosh B, et al. Notch mediates TGF alphaYinduced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell. 2003;3:565-576.
8. Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003; 425:851-856.
9. Stanger BZ, Stiles B, Lauwers GY, et al. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell. 2005;8:185-195.
10. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996; 271:350-353.
11. Wilentz RE, Iacobuzio-Donahue CA, Argani P, et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 2000;60:2002-2006.
12. Biankin AV, Kench JG, Biankin SA, et al. Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: implications for disease progression and recurrence. Am J Surg Pathol. 2004;28:1184-1192.
13. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002;15:1087-1095.
14. Yanagisawa A, Ohtake K, Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res. 1993;53:953-956.
15. Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437-450.
16. Sakai Y, Yanagisawa A, Shimada M, et al. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas. Hum Pathol. 2000;31:795-803.
17. Hori Y, Fukumoto M, Kuroda Y. Enrichment of putative pancreatic progenitor cells from mice by sorting for Prominin1 (CD133) and PDGFRA. Stem Cells. 2008;26:2912-2920.
18. Immervoll H, Hoem D, Sakariassen PO, et al. Expression of the Bstem cell marker[ CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer. 2008;8:48.
19. Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313-323.
20. Longnecker DS, Adler G, Hruban RH, et al. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System: WHO Classification of Tumours. Lyon, France: IARC Press; 2000:237-240.
21. Fargeas CA, Corbeil D, Huttner WB. AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature. Stem Cells. 2003;21:506-508.
22. Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors. J Clin Invest. 2008;118:2111-2120.
23. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794-799.
24. Bader BL, Franke WW. Cell type-specific and efficient synthesis of human cytokeratin 19 in transgenic mice. Differentiation. 1990; 45:109-118.
25. Parsa I, Longnecker DS, Scarpelli DG, et al. Ductal metaplasia of human exocrine pancreas and its association with carcinoma. Cancer Res. 1985;45:1285-1290.
26. Bockman DE, Guo J, Buchler P, et al. Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Lab Invest. 2003;83:853-859.
27. Wagner M, Luhrs H, Kloppel G, et al. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology. 1998;115:1254-1262.
28. Wagner M, Greten FR, Weber CK, et al. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev. 2001;15:286-293.
29. Schmid RM. Acinar-to-ductal metaplasia in pancreatic cancer development. J Clin Invest. 2002;109:1403-1404.
30. Oshima Y, Suzuki A, Kawashimo K, et al. Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting. Gastroenterology. 2007;132:720-732.